IGC Pharma Inc - Company Profile
Powered by 
All the data and insights you need on IGC Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date IGC Pharma Inc Strategy Report
- Understand IGC Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
IGC Pharma Inc (IGC), formerly India Globalization Capital Inc, develops and commercializes cannabis-based therapies to treat Alzheimer’s and Parkinson’s diseases. It offers solutions for the symptoms including pain, nausea, eating disorders, and epilepsy in humans, dogs, and cats. Its products include Hyalolex, IGC-501, Holi Hemp Serosapse, and Natrinol. The company also operates in the infrastructure business in India and Hong Kong. It provides rental services for heavy construction equipment such as bulldozers, excavators, rollers and pavers. IGC also executes construction contracts along with resale and purchase of physical commodities utilized in infrastructure such as steel, marble and tiles. It has business presence in the US, India, Malaysia, Mauritius and Hong Kong. IGC is headquartered in Timonium, Maryland, the US.
Headquarters
United States of America
Address
2405 York Road, Suite 201, Lutherville-Timonium, Maryland, 21093-2264
Website
igcpharma.com
Telephone
1 301 9830998
No of Employees
61
Industry
Construction
Ticker Symbol & Exchange
IGC (AFM)
Revenue (2022)
$911,000
129.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
23.4%
(2022 vs 2021)
Market Cap*
$29.2M
Net Profit Margin (2022)
XYZ
66.6%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Products | Services | Brands |
|---|---|---|
| Phytocannabinoid-based Therapies | Rental of Heavy Construction Equipment | Hyalolex |
| Natrinol | ||
| Holi Hemp |
Competitor Comparison
| Key Parameters | IGC Pharma Inc | Texas Instruments Inc | Asia Allied Infrastructure Holdings Ltd | InMed Pharmaceuticals Inc | Bardai Pvt. Ltd. |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Hong Kong | Canada | India |
| City | Lutherville-Timonium | Dallas | Hong Kong | Vancouver | Mumbai |
| State/Province | Maryland | Texas | - | British Columbia | Maharashtra |
| No. of Employees | 61 | 34,000 | 6,700 | 13 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Richard Prins | Chairman | Executive Board | 2012 | 66 |
| Ram Mukunda | Director; Chief Executive Officer; President | Executive Board | 2005 | 64 |
| Claudia Grimaldi | Chief Financial Officer; Chief Compliance Officer; Director; Principal Financial Officer; Vice President | Executive Board | 2018 | 52 |
| Rohit Goel | Principal Accounting Officer | Senior Management | 2017 | 27 |
| John E. Lynch | Director | Non Executive Board | 2021 | 85 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer